Nov 6 (Reuters) - Bausch Health Companies Inc BHC.TO :
* BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD-QUARTER 2018 RESULTS
* QTRLY REVENUES OF $2.136 BILLION
* Q3 LOSS PER SHARE $1.00
* SEES FY 2018 REVENUE $8.15 BILLION TO $8.35 BILLION
* MAINTAINED REVENUE GUIDANCE RANGE AND RAISED FULL-YEAR ADJUSTED EBITDA (NON-GAAP) GUIDANCE RANGE
* BAUSCH HEALTH - MAINTAINED FULL-YEAR REVENUE GUIDANCE RANGE FOR 2018 AND HAS RAISED ITS FULL-YEAR ADJUSTED EBITDA (NON-GAAP) GUIDANCE RANGE FOR 2018
* SEES FULL-YEAR ADJUSTED EBITDA (NON-GAAP) IN RANGE OF $3.30 - $3.45 BILLION FROM $3.20 - $3.35 BILLION
* TAKING PROACTIVE STEPS TO IMPROVE WORKING CAPITAL THROUGH AN ONGOING EFFICIENCY INITIATIVE, PROJECT CORE
* AS PART OF PROJECT CORE, PLANS TO PROACTIVELY REDUCE U.S. CHANNEL INVENTORY IN Q4 OF 2018
* Q3 EARNINGS PER SHARE VIEW $0.83, REVENUE VIEW $2.08 BILLION -- THOMSON REUTERS I/B/E/S